Q4 2025
Read transcript →IN
Indivior Pharmaceuticals Inc (INDV)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$34.23
-0.23%
Mkt Cap $4.15B
Q3 2025
Read transcript →Q2 2025
Read transcript →Q1 2025
Read transcript →Q4 2024
Read transcript →Q3 2024
Read transcript →Q2 2024
Read transcript →Q1 2024
Read transcript →Q4 2023
Read transcript →Q3 2023
Read transcript →Q2 2023
Read transcript →Q1 2023
Read transcript →Q4 2022
Read transcript →Q3 2022
Read transcript →Q2 2022
Read transcript →Q1 2022
Read transcript →Q4 2021
Read transcript →Q3 2021
Read transcript →Q2 2021
Read transcript →Q1 2021
Read transcript →Q4 2020
Read transcript →Q3 2020
Read transcript →Q2 2020
Read transcript →Q1 2020
Read transcript →Q4 2019
Read transcript →Q3 2019
Read transcript →Q2 2019
Read transcript →Q1 2019
Read transcript →Q4 2018
Read transcript →Q3 2018
Read transcript →Q2 2018
Read transcript →Q1 2018
Read transcript →Q4 2017
Read transcript →Q3 2017
Read transcript →Q2 2017
Read transcript →Q1 2017
Read transcript →Q4 2016
Read transcript →